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Healthcare‐associated infections (HCAIs) affect hundreds of millions of patients,
representing a significant burden for public health. They are usually associated to
multidrug resistant bacteria, which increases their incidence and severity. Blood-
stream infections are among the most frequent and life‐threatening HCAIs, with
Enterococcus and Staphylococcus among the most common isolated pathogens. The
correct and fast identification of the etiological agents is crucial for clinical decision‐
making, allowing to rapidly select the appropriate antimicrobial and to prevent from
overuse and misuse of antibiotics and the consequent increase in antimicrobial re-
sistance. Conventional culture methods are still the gold standard to identify these
pathogens, however, are time‐consuming and may lead to erroneous diagnosis,
which compromises an efficient treatment. (Bacterio)phage receptor binding pro-
teins (RBPs) are the structures responsible for the high specificity conferred to
phages against bacteria and thus are very attractive biorecognition elements with
high potential for specific detection and identification of pathogens. Taking into
account all these facts, we have designed and developed a new, fast, accurate,
reliable and unskilled diagnostic method based on newly identified phage RBPs and
spectrofluorometric techniques that allows the multiplex detection of Enterococcus
and Staphylococcus in blood samples in less than 1.5 hr after an enrichment step.
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1 | INTRODUCTION
Healthcare‐associated infections (HCAIs), also known as “nosoco-
mial” or “hospital‐acquired,” are infections that were not present at
the time of admission and appear 48 hr or more after hospitalization
or within 30 days after patients having received health care (Haque,
Sartelli, McKimm, & Bakar, 2018; WHO, 2002).
HCAIs rank among the top 10 leading causes of death and
increased morbidity among hospitalized patients (Haque
et al., 2018; WHO, 2002). The Center for Disease Control and
Prevention (CDC) estimates that in the United States nearly
1.7 million hospitalized patients annually acquire HCAIs while
being treated for other health issues and that more than 98,000
of these patients die due to HCAIs (Klevens et al., 2007).
Sílvio B. Santos and Alexandra P. Cunha contributed equally to this study.
In Europe, more than 2.5 million new cases of HCAIs occur every
year (Cassini et al., 2016).
HCAIs are usually associated to multidrug resistant bacteria due
to the widespread use of antimicrobials for therapy or prophylaxis
promoted by the healthcare environment (Khan, Baig, & Mehboob,
2017; WHO, 2002). Currently, antibiotic resistance is a massive
public health challenge and besides increasing the incidence and
negative impact of HCAIs, it greatly complicates treatment to a level
that can go up to the inexistence of efficient antimicrobials against
the bacterial etiological agents (Khan et al., 2017; WHO, 2002).
From the different types of HCAIs, bloodstream infections (BSIs)
are among the most frequent and with highest mortality incidence
rates (Haque et al., 2018; Khan et al., 2017). The pathogens re-
sponsible for these infections include mainly bacteria and less fre-
quently viruses and fungal parasites (Khan et al., 2017). From these,
Enterococcus (mainly E. faecalis and E. faecium) and Staphylococcus
(mostly S. aureus and coagulase‐negative staphylococci [CoNS]) ac-
count for the most common isolated pathogens (European Centre for
Disease Prevention & Control, 2018; Haque et al., 2018; Horan,
Andrus, & Dudeck, 2008; Khan et al., 2017). The emergence of
antibiotic‐resistant strains of these pathogens, such as the well‐
known methicillin‐resistant S. aureus and vancomycin‐resistant en-
terococci, increases their incidence and threatens the effective con-
trol of these bacteria with a consequently significant burden on the
global healthcare system, particularly in low resource countries
(Amin & Deruelle, 2015; Haque et al., 2018; Khan, Ahmad, &
Mehboob, 2015; Khan et al., 2017). The CDC estimates that ∼50% of
the antibiotics that are prescribed are unnecessary (Colgan &
Powers, 2001), which is one of the main causes of antibiotic resistance.
In the absence of a fast and correct diagnosis, and giving the severity
of infections, clinicians often resort to empirical broad‐spectrum
antimicrobials, with the corresponding associated consequences (Carlet
et al., 2011). Moreover, the administration of an inadequate anti-
microbial therapy within the first 24 hr causes a rapid decline in patient
survival rates (Harbarth et al., 2003; Kumar et al., 2009).
Conventional culture methods are still the gold standard for diag-
nosis of BSIs, but their accuracy is affected or even hampered by the
presence of antibiotics when samples are obtained during antimicrobial
treatment. Moreover, the results obtained by these methods can take
up to 72 hr to be conclusive due to the low levels of bacteria normally
present in samples and their slow growth (Grace, Lieberman, Pierce, &
Littenberg, 2001; Murray & Masur, 2012; Peters, Agtmael, Danner,
Savelkoul, & Vandenbroucke‐Grauls, 2004). Molecular methods, like
those based on polymerase chain reaction (PCR), offer a fast alternative
to conventional techniques and can overcome many of the pointed
limitations, due to their specificity, high sensitivity, and enrichment
culture avoidance (Peters et al., 2007; Wilson, 1997). However, there
are many factors that can compromise these methods: the occurrence
of PCR reaction inhibitors, especially in blood; the efficiency of DNA
recovery is highly variable and dependent on the type of samples; and a
high number of false positives occurs due to the presence of DNA from
dead bacteria (Al‐Soud & Rådström, 2001; Cangelosi & Meschke, 2014;
Cogswell, Bantar, Hughes, Gu, & Philipp, 1996; Navarro, Segura, Jesus
Castano, & Solera, 2006; Wilson, 1997). Immunoassays offer a simple
and rapid detection of microorganisms but their efficiency is strongly
dependent on the antibodies affinity and specificity towards the target
pathogen with the consequent appearance of false‐positive results due
to the occurrence of antibody cross‐reactions. Moreover, antibodies can
be expensive and have a limited shelf‐life with a stability that depends
on the pH and temperature conditions (Velusamy, Arshak, Korostynska,
Oliwa, & Adley, 2010).
Bacteriophages (phages) are bacterial viruses known for their
high specificity against the target bacteria that can go up to the strain
level. This specificity is conferred by the phage receptor binding
proteins (RBPs), highly variable structures of the phage particle that
are responsible for recognizing specific receptors on the cell surface
(Casjens & Molineux, 2012). Consequently, RBPs are powerful tools
for specific pathogen detection and have shown high potential in
diagnostics (S. B. Santos, Costa, Carvalho, Nóbrega, & Azeredo, 2018;
Simpson, Sacher, & Szymanski, 2016; Singh, Arutyunov, Szymanski, &
Evoy, 2012; Sumrall et al., 2020). These proteins overcome some of
the limitations of antibodies that hamper their use in in situ appli-
cations, for example, pH, temperature, and protease sensitivity, while
exhibiting comparable or even superior specificity and affinity (S. B.
Santos et al., 2018; Simpson et al., 2016; Singh et al., 2012). The
intrinsic characteristics of RBPs make them attractive biorecognition
elements on a variety of methodologies for the rapid and specific
detection and identification of bacterial pathogens. Fluorescence
spectroscopy has shown to be a useful analytical approach in many
fields, particularly in the detection of bacteria from biological sam-
ples, improving diagnosis and clinical care (Shakibaie, Lamard,
Rubinsztein‐Dunlop, & Walsh, 2018).
In this study, we aimed at designing and developing a simple and
fast spectrofluorometric multiplex assay based on phage RBPs to
detect Enterococcus and Staphylococcus in blood samples. To accom-
plish this, we identified phage RBPs targeting specifically these two
pathogens and fused them to different fluorescent proteins, detect-
able by spectrofluorometry, allowing to discriminate both bacteria in
a single analysis.
2 | MATERIAL AND METHODS
2.1 | Bacterial strains and growth conditions
The bacterial strains used in this study (Table 1) comprised: 25
strains of Staphylococcus (S. aureus, S. epidermidis, S. warneri, S. capitis,
S. equorum, S. hominis, S. haemolyticus); 23 strains of Enterococcus
(E. faecalis, E. faecium, E. gallinarum); 8 strains of other bacterial
genera as Escherichia coli, Klebsiella pneumoniae, Acinetobacter bau-
mannii and Pseudomonas aeruginosa. E. coli TOP10 and E. coli BL21
(DE3) were used for cloning and protein expression. Bacterial
strains were routinely grown in Tryptic Soy Broth (TSB; VWR
Chemicals) and in Lysogeny Broth (LB; Liofilchem) at 37°C in liquid
medium (120 rpm) or in solid medium (through the addition of 12 g/
L of agar; Liofilchem).
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2.2 | Bioinformatic analysis of potential RBPs
The E. faecalis vB_EfaS_Max phage (Melo, Ferreira, Costa, Oliveira, &
Azeredo, 2019) and the S. aureus vB_SauM‐LM12 phage (Melo, Brandao,
Akturk, Santos, & Azeredo, 2018) were selected from our collection due
to their infection ability against Enterococcus and Staphylococcus. The
phage genomes were sequenced and annotated (GenBank accession
numbers MK360024.1 and MG721208.1, respectively) and searched
for potential RBPs. These proteins were selected based on the existence
of homologs resembling RBPs deposited on the National Center for
Biotechnology Information (NCBI) nonredundant protein database
identified through BLASTp (Altschul, Gish, Miller, Myers, & Lipman,
1990) and also on structure prediction through HHpred (Zimmermann
et al., 2018). Moreover, predicted functional domains were identified
through Motif Search (http://www.genome.jp/tools/motif), Pfam (Finn
et al., 2013), and InterProScan (Jones et al., 2014). The molecular weight
TABLE 1 Bacterial strains used in this study and binding ability of




Bacterial strain Micr Spectr Micr Spectr
S. aureus Sa12 + 1.00 − 0.01
S. aureus Sa3 + 0.48 − 0.01
S. aureus Sa17 + 0.65 − 0.02
S. aureus Sa18 +/− 0.51 − 0.02
S. aureus Sa25 + 0.44 − 0.01
S. aureus 097 + 0.44 − 0.05
S. aureus C017 + 0.38 − 0.01
S. aureus C060 +/− 0.42 − 0.01
S. aureus C101 + 0.38 − 0.01
S. aureus C117 + 0.42 − 0.00
S. aureus C411A + 0.47 − 0.01
S. aureus C577 + 0.46 − 0.04
S. aureus C610 + 0.40 − 0,01
S. aureus I366 + 0.59 − 0.01
S. aureus I642 + 0.55 − 0.01
S. epidermidis RP62A +/− 0.60 − 0.01
S. epidermidis M129 + 0.98 − 0,01
S. epidermidis SECOM 020A.1 + 1.00 − 0.01
S. epidermidis IE186 + 0.99 − 0.01
S. epidermidis PT12003 +/− 0.19 − 0.01
S. warneri SECOM F16 +/− 0.16 − 0.01
S. capitis SECOM 052 A − 0.13 − 0.01
S. equorum SECOM 060 A +/− 0.38 − 0.01
S. hominis SECOM M11 + 0.42 − 0.01
S. haemolyticus SECOM 065 A.1 +/− 0.18 − 0.01
E. faecalis I809 − 0.01 + 1.00
E. faecalis LMV‐034 − 0.01 +/− 0.13
E. faecalis LMV‐036 − 0.01 + 0.99
E. faecalis LMV‐038 − 0.01 − 0.13
E. faecalis LMV‐039 − 0.01 + 0.99
E. faecalis LMV‐040 − 0.02 − 0.19
E. faecalis LMV‐056 − 0.03 + 0.91
E. faecalis I018 − 0.01 − 0.13
E. faecalis I640 − 0.03 + 0.71
E. faecalis I899 − 0.02 + 0.52
E. faecalis I900 − 0.01 + 0.52




Bacterial strain Micr Spectr Micr Spectr
E. faecalis I980 − 0.04 + 0.70
E. faecalis 25 − 0.01 + 0.59
E. faecalis 27 − 0.02 − 1.00
E. faecalis U583 − 0.01 − 0.17
E. faecalis CECT 184 − 0.02 + 0.70
E. faecium LMV‐037 − 0.02 − 0.05
E. faecium LMV‐041 − 0.01 − 0.18
E. faecium I406 − 0.05 + 0.52
E. faecium I951 − 0.03 − 0.17
E. faecium LMV‐042 − 0.01 +/− 0.51
E. gallinarum I936 − 0.01 − 0.05
E. coli 3 − 0.03 − 0.00
E. coli 6 − 0.04 − 0.05
K. pneumoniae 23 − 0.03 − 0.01
K. pneumoniae 24 − 0.04 − 0.01
A. baumannii 13 − 0.02 − 0.00
A. baumannii 14 − 0.01 − 0.01
P. aeruginosa PA01 − 0.03 − 0.01
P. aeruginosa H37783E2A‐1 − 0.01 − 0.00
Note: For microscopy analysis, (+) indicates that cells are decorated with a
high fluorescent intensity; (+/−) indicates that cells are decorated with a
low fluorescent intensity; and (−) indicates that no fluorescent intensity
was observed around the cells. For spectrofluorometric analysis, the
fluorescent signal acquired (a.u.) was normalized against the signal
obtained for the RBP incubated with the phage host strain. Normalized
values <0.05 were considered negative.
Abbreviations: Micr, microscopy; RBPs, receptor binding proteins; Spectr,
spectrofluorometry.
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and isoelectric point of the proteins were calculated using the Compute
pI/Mw program ExPASy (Artimo et al., 2012).
2.3 | Cloning of the selected genes
The red fluorescent mCherry gene derived from the DsRed of Dis-
cosoma sea anemones and the Aequorea coerulescens green fluorescent
protein (GFP) gene were inserted into the plasmid pET28a(+)
(Novagen), between the NdeI and BamHI restriction sites conserving
the plasmid N‐terminal hexa‐histidine (His)‐tag sequence and origi-
nating the plasmids pET_mCherry (Akturk et al., 2019) and pET_GFP
(S. B. Santos, Oliveira, Melo, & Azeredo, 2019), correspondingly. Pri-
mers with the desired enzyme restriction sites at the 5′‐terminus were
designed to amplify the selected genes (Table 2). Primer melting
temperatures were calculated using OligoCalc (Kibbe, 2007) and the
genes were amplified (annealing temperature of 55°C) with Phusion
DNA Polymerase (Thermo Fisher Scientific) according to manu-
facturer's instructions. The corresponding phage DNA was used as
template and the amplified DNA was digested with the corresponding
restriction enzymes (SacI and XhoI). The digested amplicons originated
from the E. faecalis and S. aureus phages were respectively inserted into
the pET_mCherry and pET_GFP (to fuse them with the fluorescent
protein upstream, at the N‐terminus) and ligated with the T4 ligase
(Thermo Fisher Scientific) to obtain the different constructions, further
used to transform E. coli TOP10 competent cells (Invitrogen). The re-
sulting fused proteins were named as mCherry‐gp17, mCherry‐gp18,
GFP‐gp109, and GFP‐gp111. Colonies were screened through colony
PCR and positives were used for plasmid extraction and further con-
firmation through Sanger sequencing. Correct plasmids were used to
transform competent E. coli BL21 (DE3) cells (Invitrogen).
2.4 | Expression and purification of the fused
proteins
E. coli BL21 cells harboring the recombinant plasmids were grown
at 37°C in LB medium supplemented with 50 mg/L of kanamycin
until reaching an optical density (OD) at 620 nm (OD620 nm) of 0.6.
Recombinant protein expression was induced with 1 mM isopropyl‐
β‐D‐thiogalactopyranoside (Sigma‐Aldrich), followed by incubation
overnight at 16°C, 120 rpm. Cells were harvested by centrifugation
(9,000 × g, 15 min) and further resuspended in phosphate lysis
buffer (20 mM sodium dihydrogen phosphate, 500 mM sodium
chloride, pH 7.4). Cell disruption was made by thaw‐freezing (three
cycles, from −80°C to room temperature) followed by a 5 min so-
nication (Cole‐Parmer Ultrasonic Processor) for 10 cycles (30 s ON
and 30 s OFF) at 40% amplitude. Soluble cell‐free extracts were
separated by centrifugation, filtered, and loaded on a 1 ml
HisPur™Ni‐NTA Resin (Thermo Fisher Scientific) stacked into a
polypropylene column (Qiagen). After two washing steps with
protein‐dependent imidazole concentrations (lysis buffer supple-
mented with 20 mM imidazole in the first wash and 40 mM imi-
dazole in the second wash), the protein was eluted with 300 mM
imidazole. Protein fractions were observed through sodium dode-
cyl sulfate‐polyacrylamide gel electrophoresis (12% wt/vol acryla-
mide), followed by Blue Safe staining (NZYTech). The purified
proteins were concentrated and dialyzed against 0.1 M phosphate
buffer pH 7.2 (PB) using the centrifugal filters Amicon Ultra 0.5 ml
MWCO 10 KDa (Merck Millipore) and stored at 4°C. Protein con-
centration was determined using the Bicinchoninic Acid Protein
Assay Kit (Thermo Fisher Scientific) with bovine serum albumin as
standard.
2.5 | Functional analysis of the RBPs and specificity
assays by epifluorescence microscopy
The binding ability of the different constructions (potential RBPs
fused to the fluorescent proteins) was inferred by epifluorescence
microscopy observations of the corresponding phage host cells
(E. faecalis I809 or S. aureus Sa12) after incubation with the
fused proteins (mCherry‐gp17 and mCherry‐gp18 or GFP‐gp109 and
GFP‐gp111, respectively). The mCherry or GFP alone were used as
negative controls to discard unspecific binding by the fluorescent
proteins to E. faecalis or S. aureus cells.
TABLE 2 Primers used to amplify the selected genes and the respective restriction enzymes used









Note: Restriction endonuclease sites are underlined.
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Briefly, bacterial cells were grown in liquid TSB at 37°C until
mid‐log phase (OD620nm = 0.3–0.4) and then the culture was cen-
trifuged for 5min at 9,000 × g, followed by resuspension in the same
volume of PB. A volume of 500 µl of each bacterial suspension was
centrifuged at 9,000 × g for 5min. The pellet was resuspended in
20 µl of 5 µM purified protein and incubated for 30min at room
temperature. The cells were washed two times with PB by cen-
trifugation to remove the unbound protein. The washed pellet was
resuspended in 10 µl of PB and observed at the epifluorescence
microscope equipped with U‐RFL‐T light source (Olympus BX51,
magnitude ×1,000) in bright field (BF) and under the TRITC (530‐
550; LP‐591) or fluorescein isothiocyanate (FITC; 470‐490; LP‐516)
filters, depending on the fluorescent protein (mCherry or GFP, re-
spectively). Control samples using PB instead of the fused re-
combinant proteins were prepared simultaneously.
The proteins mCherry‐gp18 and GFP‐gp109 were selected and
tested for their specificity and sensitivity against the strains listed in
Table 1, following the procedure described above.
2.6 | Spectrofluorometric assays
Overnight cultures of E. faecalis I809 and S. aureus Sa12 grown on
TSB at 37°C, 120 rpm were centrifuged at 4,670 × g for 10min and
the cell pellets resuspended in 0.1M PB (pH 7.2) setting the OD620 to
0.6. The bacterial suspensions (1 ml) were centrifuged at 9,000 × g for
5min and concentrated 10 times in PB. Afterwards, a 120 μl reaction
was set by adding 40 μl of one or both bacterial suspensions and
20 μl of one or both purified fused proteins (GFP‐gp109 or mCherry‐
gp18) at a final concentration of 2.5 μM (when necessary PB was
added to achieve the final reaction volume). The reaction was in-
cubated at room temperature for 30min. Cells were centrifuged
(9,000 × g for 5 min) and then washed twice with PB at the same
conditions to remove unbound protein and resuspended in 120 μl of
PB. Each sample (100 μl) was analyzed in a 96‐well black microplate
through a BioTek™ Synergy™ H1 Hybrid Multi‐Mode Microplate
Reader with the BioTek Gen5 data analysis software. Excitation/
emission (gain) was set to 470/510 nm (70) and to 570/610 nm (100)
to analyze the protein fused to GFP and mCherry respectively, with
the fluorescence intensity expressed in arbitrary units (a.u.). Two
independent experiments with duplicates were performed for each
sample and negative and positive controls were also included. Ne-
gative controls were: S. aureus Sa12 incubated with mCherry‐gp18;
E. faecalis I809 incubated with GFP‐gp109; unstained bacteria; sam-
ples with only the fused proteins without bacterial cells. Positive
controls comprised E. faecalis I809 with mCherry‐gp18 and S. aureus
Sa12 with GFP‐gp109.
The proteins mCherry‐gp18 and GFP‐gp109 were tested as
described above against the strains listed in Table 1 to assess their
specificity and sensitivity on the developed spectrofluorometric
assay.
To determine the detection limit, suspensions of S. aureus Sa12
and E. faecalis I809 were prepared as previously described and
diluted into different concentrations, ranging from 1 to 108 colony‐
forming unit (CFU)/ml. Samples were treated and analyzed by spec-
trofluorometry, as mentioned above.
Assessing the detection of S. aureus and E. faecalis in blood was
accomplished by artificially contaminate 5ml of horse blood (Pro-
biológica) with 1–5 CFU/mL. The spiked blood sample (as well as a
negative control composed of noncontaminated blood) was in-
cubated with 45ml of TSB for ∼15 hr at 37°C, 120 rpm. Afterwards,
1 ml of each sample was diluted ten times in ultrapure water to
promote osmotic lysis of erythrocytes, centrifuged at 4,670 × g for
10min and washed twice with 10ml of PB at the same conditions.
This suspension was then used to prepare the reaction mixture with
the fused proteins (GFP‐gp109 or mCherry‐gp18), using the same
procedure described above for the analysis of contaminated buffer
samples.
2.7 | Statistical analysis
All results were analyzed by one‐way analysis of variance test. The
data are presented as means and standard deviations. Differences
between samples were considered statistically significant for p ≤ .05.
3 | RESULTS
3.1 | Bioinformatic analysis of potential RBPs
Tail proteins, mainly those from the minor tail, major tail, and tail
fibers, are often associated with phage RBPs (Simpson et al., 2016).
The genomic analysis of the E. faecalis vB_EfaS_Max and the S. aureus
vB_SauM‐LM12 phages enabled the identification of genes encoding
those proteins, which may act as RBPs.
Concerning the E. faecalis phage, we have selected as potential
RBPs two gene products (gp) that have homology with proteins from
phage tails deposited at the NCBI nonredundant database. The gp17
has homology with tail/tail minor proteins from other Enterococcus
phages but also with tail fibers from Lactobacillus prophages.
Accordingly, HHpred found hits with a distal tail protein/RBP
from Lactococcus phages (PDB 4V96_AT and 5LY8_A, at the N‐ and
C‐terminus, respectively). Domains from the Sipho_tail and
phi3626_gp14_N families (which comprise tail component proteins
from a number of phages) were also identified (Figure 1). The gp18,
besides presenting many tail assembly protein homologs, also aligns
with many minor tail proteins from other Enterococcus phages. In
their great majority, and in contrast with gp17, the homologs align
only at the N‐terminus, showing that the C‐terminus is highly vari-
able, a common feature among RBPs (Dupont, Vogensen, Neve,
Bresciani, & Josephsen, 2004; Santos et al., 2018; Singh et al., 2012).
Moreover, the N‐terminus presents an identifiable Prophage_tail
superfamily and a Phage minor structural protein, N‐terminal do-
main. The Prophage_tail superfamily is a family of prophage tail
proteins that probably act as endopeptidases, which might suggest
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that gp18 is likely a tailspike. Homology with distal tail protein/tail tip
from a Staphylococcus phage (PDB 6V8I_BE) was also found with
HHpred (Figure 1).
On the Staphylococcus phage genome, we have also selected two
proteins based on the bioinformatics analysis. The gp109 revealed a
number of tail fibers and some RBP homologs. PFAM and InterPro
failed to identify any conserved domain, while HHpred found
homology with the Staphylococcus phage K putative RBP (PDB
5M9F_A) at the C‐ terminus and with the Staphylococcus phage phi11
phage adsorption/wall teichoic acids interacting protein (PDB
5EFV_A) and the RBP of Staphylococcus phage P68 (PDB 6IAB_A) at
the N‐terminus (Figure 1). Carbohydrate‐binding domain‐containing
proteins and some RBPs (all from other Staphylococcus phages) were
found as homologs to the gp111. A carbohydrate‐binding domain was
found at the middle of the protein sequence and InterPro also
identified domains related to carbohydrate‐binding, cellulose‐binding
and galactose‐binding (CenC_carb‐bd). As with gp109, homology with
the Staphylococcus phage K putative RBP (PDB 5M9F_A) at the
C‐terminus was identified with HHpred (Figure 1).
3.2 | Functional analysis of the selected
potential RBPs
After the in silico identification of the potential RBPs, we have per-
formed a functional analysis of these proteins to confirm their re-
cognition binding ability.
Genes encoding hypothetical RBPs from the Enterococcus phage
(gp17 and gp18) were cloned into pET_mCherry originating the fusion
proteins mCherry‐gp17 and mCherry‐gp18, while those from the
Staphylococcus phage (gp109 and gp111) were cloned into pET_GFP
generating the fusion proteins GFP‐gp109 and GFP‐gp111. Such fu-
sion recombinant proteins enabled to infer the binding ability of the
potential RBPs through epifluorescence microscopy. If the tested
protein is a RBP, it will bind to cells and due to the N‐terminus
fluorescent protein, the cells will be decorated with fluorescence,
detectable via epifluorescence microscopy.
Functional analysis has shown that mCherry‐gp18 (Figure 2ai)
was able to bind to the E. faecalis I809 (the host for the E. faecalis
phage vB_EfaS_Max) and that GFP‐gp109 (Figure 2aii) recognized
S. aureus Sa12 (the host for the S. aureus phage vB_SauM‐LM12).
Importantly, during this analysis, it was possible to notice that all
target cells observed with the BF filter (Figure 2ai,ii BF) were
fluorescently decorated when observed with the corresponding filter
(Figure 2ai TRITC and ii FITC). Conversely, no fluorescence was ob-
served when mCherry‐gp17 and GFP‐gp111 were incubated with
their target cells, as well as the negative controls mCherry and GFP.
Considering these results, the proteins mCherry‐gp18 and
GFP‐gp109 were selected to be used in the subsequent assays.
3.3 | Specificity and sensitivity assays by
epifluorescence microscopy
Considering that we aimed at using the selected proteins
(mCherry‐gp18 and GFP‐gp109) for diagnosis and in a multiplex
approach, we have assessed the potential cross‐reaction between
these proteins as well as their specificity and sensitivity to the target
bacteria. Through this evaluation, we observed that mCherry‐gp18
and GFP‐gp109 did not recognize S. aureus Sa12 or E. faecalis I809,
F IGURE 1 In silico analysis of the phage potential RBPs. Selected proteins are represented in black identified by their gp number, followed
by their length (aa) and predicted molecular weight (kDa). Hits to protein families are denoted in blue with the family name. Homologous protein
structures are denoted in red with the homologs Protein Data Bank (PDB) identification. The forms were drawn at a relative scale in their
relative positions [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 2 Functional analysis of the phage RBPs. (a) Bacterial suspensions of Enterococcus faecalis I809 and/or Staphylococcus aureus Sa12
were combined with mCherry‐gp18 or GFP‐gp109. (b) Bacterial suspensions of E. faecalis I809 and S. aureus Sa12 were combined with mCherry‐
gp18 and GFP‐gp109 showing no cross‐reactivity and the ability to detect and discriminate all bacterial cells. (E) E. faecalis I809; (S) S. aureus
Sa12; (18) mCherry‐gp18; (109) GFP‐gp109; RBPs, receptor binding proteins [Color figure can be viewed at wileyonlinelibrary.com]
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respectively (Figure 2aiii,iv). Also, when incubating both proteins with
only E. faecalis I809 or S. aureus Sa12, no decorated cells were
observed with the FITC (green) or TRITC (red) filter, respectively
(Figure 2avii,viii). Following these results, a mixed culture of
E. faecalis I809 and S. aureus Sa12 was incubated with mCherry‐gp18
or GFP‐gp109 and, as expected, only part of the population
was decorated with red or green fluorescence, respectively
(Figure 2av,vi). When both proteins were incubated with the mixed
culture of E. faecalis I809 and S. aureus Sa12, all the cells observed
with the BF filter were decorated with red or green fluorescence,
without overlapping of both fluorescent proteins (Figure 2b).
The specificity and sensitivity of the RBPs were further assessed
by testing a panel of 25 Staphylococcus and 23 Enterococcus strains as
well as eight bacterial strains of other genera. The Staphylococcus
phage RBP (GFP‐gp109) was able to recognize all Staphylococcus
strains with the exception of the S. capitis strain and did not bind to
any non‐Staphylococcus strain, accounting for a specificity of 100%
and a sensitivity of 96%. The Enterococcus phage RBP (mCherry‐gp18)
was able to bind to most of the E. faecalis strains (11 out of 17) and to
decorate two of five E. faecium strains (Table 1). No binding of
mCherry‐gp18 to E. gallinarum and to the other strains outside the
Enterococcus genus was observed. This resulted in a specificity of
100% and a sensitivity of 57% (13 out of 23 strains) to the
Enterococcus genus.
3.4 | Spectrofluorometric assays
The epifluorescence microscopy assays allowed to functionally ana-
lyze the identified Enterococcus and Staphylococcus phage RBPs and to
assess their specificity and sensitivity against the target bacteria.
Although this equipment enables to use the fusion proteins for the
detection and identification of these two problematic pathogens, it is
a time‐ and labor‐intensive manual process, requiring expertise in
microscopy observation. Conversely spectrofluorometric analysis is a
simple methodology that does not require skilled technicians or ex-
pensive equipment. Consequently, we have designed a method based
on this technique for the multiplex detection of Enterococcus and
Staphylococcus using the phage fluorescent RBPs. First, it was im-
portant to determine the detection limit of the assay in terms of the
number of decorated cells needed to obtain a significant signal. This
was performed by analyzing 10‐fold dilutions of bacterial suspen-
sions from 1 to 108 CFU/ml decorated with the fusion RBPs. The
results showed that 108 CFU/ml are needed for an unequivocal signal
at the spectrofluorometer (Figure 3).
To assess the efficacy of the spectrofluorometric assay to detect
Staphylococcus and Enterococcus cells, the same samples submitted to
the epifluorescence microscopy (Table 1) were measured to de-
termine the specificity and sensitivity of the assay and the quality
and reproducibility of the fluorescent signal obtained. The results
(Table 1) demonstrate that high green fluorescent signals were
measured when the GFP‐gp109 protein was tested against all Sta-
phylococcus strains, including S. aureus and CoNS strains. Also, red
fluorescent signals were observed when the mCherry‐gp18 protein
was tested with Enterococcus strains, including E. faecalis and E. fae-
cium, with the exception of E. gallinarum I936 and E. faecium
LMV‐037, accounting for a sensitivity of 91%. When GFP‐gp109 and
mCherry‐gp18 were incubated with bacterial strains not belonging to
the Staphylococcus or Enterococcus genus respectively, no significant
fluorescence signals were obtained. Regarding negative controls,
when samples with unstained bacteria were analyzed, auto-
fluorescence at a wavelength of 510 nm (green) and 610 nm (red)
was not detected. Also, only residual fluorescent signals were ob-
served when samples without bacterial cells and with only the re-
combinant fused proteins (after sample processing) were measured
(Figure 4).
The ability of the spectrofluorometric assay to enable a multiplex
detection of Staphylococcus and Enterococcus cells was performed first
with bacterial suspensions in buffer to eliminate any interference
from complicated matrices. From this analysis, it was possible to
observe that an unequivocal positive signal was obtained only when
the RBP and the target bacterium was present and only at the cor-
responding fluorescent RBP's wavelengths (Figure 4a). This indicates
that a positive signal at a wavelength of 610 nm (red) was obtained
F IGURE 3 Detection limit of the spectrofluorometric assay. Serial 10‐fold dilutions of bacterial suspensions were combined with the
corresponding phage RBP and analyzed at the spectrofluorometer. (a) Enterococcus faecalis I809 with mCherry‐gp18; (b) Staphylococcus aureus
Sa12 with GFP‐gp109. RBP, receptor binding protein [Color figure can be viewed at wileyonlinelibrary.com]
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only when the Enterococcus mCherry‐gp18 RBP and a sensitive En-
terococcus strain was present in the sample, independently of the
presence of other RBP. Accordingly, a positive signal at a wavelength
of 510 nm (green) was obtained only when the Staphylococcus
GFP‐gp109 RBP and a sensitive Staphylococcus strain was present in the
sample. For samples containing both bacteria with mCherry‐gp18 or
GFP‐gp109, positive fluorescent red and green signals were detected,
respectively. These signals were very similar to the values obtained for
the individual bacterial detection, showing that the presence of both
bacteria did not interfere with their individual detection. Similarly, when
Enterococcus cells or Staphylococcus cells were incubated with both phage
proteins, only the expected fluorescent signal was obtained (red or
green, respectively). For the multiplex assay, in which a mixed culture of
Staphylococcus and Enterococcus was incubated with both proteins, a high
red and green fluorescence were attained, indicating the presence of
both decorated cells (Figure 4a).
Considering the high incidence of these pathogenic bacteria in
BSIs, we have assessed the applicability of this methodology in blood
artificially contaminated with the target bacteria. The same rationale
of the previous experiment in buffer was used herein (the same
combinations between the RBPs and target bacteria). However, taking
into account that the detection limit of the spectrofluorometric assay
is 108 CFU/ml and that the concentration of pathogens present in a
patient suffering from a BSI range from 1 to 103 CFU/ml (Bacconi
et al., 2014), the assay in blood had to include an enrichment step, to
detect roughly 1 CFU/ml of E. faecalis and S. aureus in 5ml of blood.
This procedure guarantees that the detection limit of the assay is
assured (108 CFU/ml), enabling the bacterial detection within 1.5 hr.
The results obtained in the enriched blood samples (Figure 4b)
were similar to the previous experiments with bacterial suspensions
in buffer (Figure 4a). In fact, an unequivocal positive signal was
measured only when the RBP and the target bacterium was present
and only at the corresponding fluorescent RBPs wavelengths.
Moreover, a multiplex detection of Staphylococcus and Enterococcus
was successfully achieved on artificially seeded blood samples. A
control sample of noncontaminated blood was submitted to the same
procedure, resulting in a negative signal (<100 a.u.).
4 | DISCUSSION
The high incidence of HCAIs, namely, BSIs, worldwide coupled with
their deleterious effects, make these infections a top leading cause of
death with a significant burden both for the patient and public health.
To counteract this, a fast and accurate identification of the etiological
agent is required to design and apply an efficient treatment. How-
ever, the currently available methodologies are usually time‐
consuming, requiring at least 48 hr and can go up to a few days for
the specific pathogen identification (Arabestani, Rastiany, Kazemi, &
Mousavi, 2015; Opota, Croxatto, Prod'hom, & Greub, 2015). More-
over, they are not always accurate, detecting only 30–40% of all
cases of sepsis (Arabestani et al., 2015), which leads to a high de-
crease in survival rates (Kumar et al., 2009). Therefore, there is an
urgent demand for research and development of new diagnostic
methods able to solve the problems of the existing ones, namely,
accuracy and fastness. Such methods will prevent the common
overprescription of antibiotics and their overuse‐related problems
(Garnacho‐Montero et al., 2008).
Considering that BSIs are among the most frequent HCAIs and
that Enterococcus and Staphylococcus are among the most common
isolated bacteria (European Centre for Disease Prevention & Control,
2018), we have designed and developed a new methodology for the
multiplex detection of these pathogens in blood samples based on
phage RBPs as the biorecognition elements. Accordingly, we have
searched for such proteins on the genome of phages infecting the
target pathogens: Enterococcus and Staphylococcus. Bioinformatic
analysis of genomes from E. faecalis phage vB_EfaS_Max (Melo
et al., 2019) and S. aureus phage vB_SauM‐LM12 (Melo et al., 2018)
allowed the identification of four potential RBPs, based on the
homology to other known proteins and conserved domains usually
associated with RBPs. The selected proteins were further cloned and
expressed fused to different fluorescent proteins. This approach
enabled their use in a multiplex assay, allowing to differentiate the
two target pathogens simultaneously in the same sample.
The functional analysis of the selected proteins, resulted in the
identification of one RBP from each phage with the ability to bind to
F IGURE 4 Specificity of the spectrofluorometric multiplex assays. Bacterial suspensions of Enterococcus faecalis I809 and/or Staphylococcus
aureus Sa12 were combined with mCherry‐gp18 and/or GFP‐gp109. (a) Multiplex assays performed on buffer samples. (b) Multiplex assays
performed on blood samples. (E) E. faecalis I809; (S) S. aureus Sa12; (18) mCherry‐gp18; (109) GFP‐gp109. GFP, green fluorescent protein [Color
figure can be viewed at wileyonlinelibrary.com]
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each target pathogen (gp18 for Enterococcus and gp109 for Staphy-
lococcus). Other studies have already reported the identification and
structure of RBPs from Staphylococcus phages (Kizziah, Manning,
Dearborn, & Dokland, 2020; Koç et al., 2016; Li et al., 2016). How-
ever, to the best of our knowledge, this is the first study in which the
binding affinity (specificity and sensitivity) of RBPs from Enterococcus
and Staphylococcus phages has been assessed. Such analysis has only
been reported for RBPs from phages infecting other bacterial genera
(Bielmann et al., 2015; Javed, Poshtiban, Arutyunov, Evoy, &
Szymanski, 2013)
The fact that the other two proteins (gp17 and gp111) did not
bind to the target hosts does not preclude that they do not have that
role in the phage particle but may need other ancillary proteins or
specific folding to be functional (Häuser et al., 2012; Santos
et al., 2018). Also, phages may employ more than one RBP to attach
their target bacterium and thus the identification of one RBP does
not impair the existence of others (Häuser et al., 2012; Santos
et al., 2018; Santos et al., 2011).
The potential use of RBPs for diagnosis of bacterial infections
cannot be based only on their ability to bind to a single strain and
consequently, we have performed specificity and sensitivity tests. In
the microscopy assays, the Enterococcus phage RBP gp18 showed to
be fully specific for the Enterococcus genus since it was not able to
bind to any bacterial cell outside this genus. Moreover, gp18 re-
cognized the majority of the strains of E. faecalis and some strains of
E. faecium, which is undoubtedly important to detect enterococcal‐
associated infections that are mainly caused by these species
(Kramer et al., 2018). The Staphylococcus phage RBP gp109 also
showed 100% specificity for Staphylococcus and its sensitivity was
even higher (96%) than the gp18, binding to all Staphylococcus strains,
including S. aureus and CoNS (except the S. capitis), which are the
most prevalent Staphylococcus species on BSIs (European Centre for
Disease Prevention & Control, 2018). Overall, the RBPs gp18 and
gp109 showed potential to be used for diagnosis of Enterococcus and
Staphylococcus infections, respectively.
As RBPs, the cell binding domains (CBD) of phage endolysins (phage
proteins responsible for cell lysis at the end of the lytic cycle) have
proven successful as biorecognition elements but in the particular case
of Staphylococcus phage endolysin CBDs they have been shown a spe-
cificity below 100% (Becker, Foster‐Frey, Stodola, Anacker, & Donovan,
2009; Benešík et al., 2018). This is the case of the recently described
CBD of Staphylococcus phage E‐LM12, which besides its efficacious use in
a new method for Staphylococcus detection in blood, demonstrated some
binding affinity to two Enterococcus strains (Costa et al., 2020). Conse-
quently, the increased specificity of the Staphylococcus phage RBP gp109
presents advantages as biorecognition molecules for diagnosis, poten-
tially avoiding the occurrence of false positives since these proteins did
not bind to any of the strains tested outside their target genus. The
absence of cross‐reaction between the two RBPs when used together
against the panel of strains herein tested supports their application for
the multiplex detection of Staphylococcus and Enterococcus.
Giving the potential of these proteins, we designed a simple
multiplex diagnostic method that combines the RBPs as specific
biorecognition molecules, the fluorescence of GFP and mCherry and
a spectrofluorometer. Overall, the results from the spectro-
fluorometric assays confirmed that the Enterococcus phage RBP gp18
was specific for the Enterococcus genus since it was not able to bind
to any bacterial strain outside this genus and also presented a high
sensitivity to the E. faecalis and E. faecium species, binding to 100%
and to 80% of the strains tested, respectively. The Staphylococcus
phage RBP gp109 was specific for the Staphylococcus genus, being
able to bind to all Staphylococcus strains tested.
When comparing the results obtained by this methodology with
the microscopy analysis (Table 1), the sensitivity of the spectro-
fluorometric assay was higher. In fact, despite some Enterococcus
species and the S. capitis strain have not shown fluorescence by mi-
croscopy, a fluorescence signal was detected by spectrofluorometric
analysis. Although these bacteria presented a lower fluorescence
intensity signal, it was noticeably higher than the negative controls,
allowing the detection of the stained cells (91% of the Enterococcus
and 100% of the Staphylococcus tested).
Analysis of the limit of detection of the spectrofluorometer re-
vealed that a concentration of 108 CFU/ml is required for an un-
equivocal signal (Figure 3). Considering that 1–100 CFU/ml are
usually present in circulation during a BSI (Skvarc, Stubljar, Rogina, &
Kaasch, 2013), it implies the need for a sample enrichment step be-
fore application of the designed methodology. In fact, this is the
reality of the great majority of the diagnostic methods developed to
date and only a marginal number have been described to detect
bacteria directly from blood without enrichment. Moreover, even
these methods present some drawbacks, mainly associated with their
high sensitivity (Peker, Couto, Sinha, & Rossen, 2018).
In the developed method, we were able to detect the presence of
the target pathogens in blood samples with as just as 1–5 CFU/ml in
<1.5 hr. For this, an enrichment step of 15 hr was required to achieve
a bacterial concentration (approximately 108 CFU/ml) that could be
undoubtedly detectable by spectrofluorometry. Although the en-
richment step is undesirable for fastness, it prevents the occurrence
of false negatives by guaranteeing the detection of viable cells. The
time needed for bacterial enrichment is dependent on bacterial
species, initial loads, physiological state, and on growth conditions
used (Opota et al., 2015). The use of magnetic nanoparticles or
microfluidic‐based approaches to separate and concentrate bacterial
cells before their detection can be applied to decrease the turn-
around time of the spectrofluorometric method (Sande, Çaykara,
Silva, & Rodrigues, 2020; Sumrall et al., 2020).
Another important fact of the designed method is the ability to
detect and identify bacteria without compromising its viability. This
allows the use of the identified bacterium for further antibiotic sus-
ceptibility tests, which is not possible with many other methods, such
as those based on nucleic acids, that kill or degrade the bacterial cells.
This is crucial to select the best antimicrobial and to provide an effi-
cient therapy and reduce overprescription of antibiotics and asso-
ciated adverse outcomes (Afshari, Schrenzel, Ieven, & Harbarth, 2012).
Overall, by combining the specific and sensitive binding ability of
the identified phage RBPs, the fluorescence proteins and a
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spectrofluorometer, we have designed and developed a new, accu-
rate, reliable, simple, unskilled, and fast diagnostic method to be
implemented in a diagnostic laboratory. The results validated these
properties and the applicability of phage RBPs to detect Enterococcus
and Staphylococcus easily and accurately by producing an unequivocal
fluorescent signal. With this new methodology, we were able to de-
tect low concentrations of the target pathogens in blood within 1.5 hr
(excluding the enrichment step) using a simple and relatively in-
expensive equipment. Moreover, we validated its use on blood
samples, allowing for the individual and multiplex detection of En-
terococcus and Staphylococcus, without the occurrence of false posi-
tives that could have occurred due to the autofluorescence of the
blood components (Azevedo et al., 2011). Overall, the developed
method presents several advantages over other reported diagnostic
techniques and thus can be easily implemented in any laboratory and
health care unit.
5 | CONCLUDING REMARKS
In this study, we have identified two phage RBPs for Enterococcus and
Staphylococcus that demonstrated high affinity, specificity and sen-
sitivity and thus present great potential to be used as biorecognition
elements in the development of new methodologies for bacterial
infections diagnosis. By fusing these promising proteins to fluor-
escent proteins and combining them with a spectrofluorometer able
to detect the produced signal, we have developed a new method that
enables the multiplex identification of Enterococcus and Staphylo-
coccus from blood contaminated samples. This assay demonstrated to
be accurate, reliable, simple, unskilled, relatively inexpensive, and
fast, congregating thus many desirable properties for diagnostics that
can potentially improve treatment and control of BSIs and thus de-
crease their negative impact worldwide.
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